DUBLIN–(BUSINESS WIRE)–The “Next-Generation Sequencing (NGS) Market by Product & Service (Consumables, Platforms, Services, Bioinformatics), Technology (SBS, SMRT), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) – Global Forecast to 2026” report has been added to ResearchAndMarkets.com’s providing.
The following-generation sequencing (NGS) market is projected to succeed in USD 24,244.6 million by 2026 from USD 10,298.9 million in 2021, at a CAGR of 18.7%.
Market progress is basically pushed by the developments in NGS platforms, declining prices of genome sequencing, bettering regulatory and reimbursement eventualities for NGS-based diagnostic checks, and the rising incidence of most cancers and the growing purposes of NGS in most cancers analysis.
Alternatively, end-user funds constraints in creating international locations are anticipated to restrain the expansion of this market to a sure extent. The NGS market on this report is segmented primarily based on product & service, utility, expertise, finish consumer, and area.
In 2020, Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), and Agilent Applied sciences (US) dominated the NGS market. Different distinguished gamers on this market embody Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Applied sciences (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), GENEWIZ (US), Psomagen, Inc. (South Korea), and 10x Genomics (US).
By product & service, the NGS consumables phase accounted for the biggest share of the next-generation sequencing market.
The following-generation sequencing market by product is categorized into main consumables and tools. NGS consumables dominated the market in 2020. The big share of this phase could be attributed to the rising variety of sequencing procedures and the launch of easy-to-use consumables.
Asia Pacific: The fastest-growing area within the next-generation sequencing market.
The Asia Pacific market is projected to develop on the highest CAGR in the course of the forecast interval, primarily as a result of growing variety of NGS-based analysis initiatives, the rising variety of most cancers instances, and rising consciousness about precision medication.
North America: the biggest share of the next-generation sequencing market.
North America accounted for the biggest share of the next-generation sequencing market. Components resembling the supply of analysis funding and the event of NGS information evaluation options are the most important elements driving the market progress.
Breakdown of primaries
Key Matters Lined:
2 Analysis Methodology
3 Government Abstract
4 Premium Insights
4.1 Subsequent-Era Sequencing Market Overview: Developments in NGS Platforms to Drive Market Development
4.2 NGS Consumables Phase Accounted for the Largest Share of the North American NGS Market in 2020
4.3 Diagnostics Phase Will Proceed to Dominate the NGS Market in 2026
4.4 Educational Institutes & Analysis Facilities Phase Accounted for the Largest Market Share in 2020
4.5 Asia-Pacific Market to Register the Highest Development within the NGS Market from 2021 to 2026
5 Market Overview
5.2 Market Dynamics
188.8.131.52 Developments in NGS Platforms
184.108.40.206.1 Iseq 100 System
220.127.116.11.2 Ion Genestudio S5
18.104.22.168 Declining Prices of Genome Sequencing
22.214.171.124 Enhancing Regulatory and Reimbursement State of affairs for NGS-Based mostly Diagnostic Assessments
126.96.36.199 Rising Incidence of Most cancers and Growing Functions of Subsequent-Era Sequencing in Most cancers Analysis
188.8.131.52 Finish-Consumer Finances Constraints in Growing Nations
184.108.40.206 Authorities & Personal Help for Giant-Scale Sequencing
220.127.116.11 Utility of NGS in Precision Drugs and Molecular Diagnostics
18.104.22.168 NGS Information Evaluation Utilizing Huge Information
22.214.171.124 Interpretation of Complicated Information from NGS Platforms
126.96.36.199 Moral Points
188.8.131.52 Introduction of Various Applied sciences
5.2.5 Business Traits
184.108.40.206 Growth of Moveable Sequencing Applied sciences
220.127.116.11 Partnerships & Collaborations for Technological Developments in NGS
5.3 Influence of the COVID-19 Outbreak on the Subsequent-Era Sequencing Market
5.4 Porter’s 5 Forces Evaluation
5.5 Worth Chain Evaluation
5.6 Technological Evaluation
5.7 Ecosystem Evaluation
5.8 Patent Evaluation
5.9 Pricing Evaluation
5.10 Regulatory Evaluation
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Bgi Group
- Qiagen N.V.
- F. Hoffmann-La Roche Ag
- Eurofins Scientific
- Agilent Applied sciences, Inc.
- Pacific Biosciences
- Oxford Nanopore Applied sciences
- Genewiz (A A part of Brooks Automation)
- Psomagen, Inc. (Previously Generally known as Macrogen)
- 10X Genomics
- Nugen Applied sciences (A A part of the Tecan Group)
- Zymo Analysis
- Takara Bio
- Hamilton Firm
- Beckman Coulter (A Subsidiary of Danaher Company)
- Becton, Dickinson and Firm
- Genotypic Know-how
- Lucigen Company
For extra details about this report go to https://www.researchandmarkets.com/r/c3xl5e